4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-026255
Chief Executive Officer sold 19,388 shares at $0.70 ($13,572)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-07-18 | Sale | −19,388 | $0.70 | $13,572 | 3,899,469 | D |
| Open-market sales · 19,388 sh · avg $0.70 · $13,572 | |||||||
Loading xslF345X03/doc4.xml…